This observation, and the previous observation that CK2α tyrosine phosphorylation by BCR-ABL affects the CK2 kinase activity, suggests that in CML CK2 not only is just a constitutively active kinase but also can be somehow regulated. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.